MARKETING RESEARCH OF VENOPROTECTIVE DRUG DETRALEX

Abstract

 As of today, varicose veins occur in 10-40% of the working population of developed countries. The most effective means of managing this pathology is venoprotective drugs. The purpose of the research was the marketing analysis of the drug "Detralex", which revealed that the majority of patients know and have used Detralex, applies self-medication and takes responsibility for his own health. When choosing medicines, the price is a priority for the majority of patients, which is caused by the social situation in the country.